Biotech Grand Prix 2023

NEWS

News

2024/10/14 Biotech Grand Prix 2024: Grand Prize Won by SPHinX

Grand Prix
News
Biotech Grand Prix

2024/10/09 Biotech Grand Prix 2024 to be held

News
Biotech Grand Prix

2024/04/08 TECH PLANTER revamps its logo and evolves into a mechanism to further accelerate business creation.

Agritech Grand Prix
Ecotech Grand Prix
Grand Prix
Deep Tech Grand Prix
News
Biotech Grand Prix
Food Tech Grand Prix
Marintec Grand Prix
Lifetech Grand Prix

2023/12/04 Tech Planter 2024 call for entries is now open!

Agritech Grand Prix
Ecotech Grand Prix
Grand Prix
Deep Tech Grand Prix
News
Biotech Grand Prix
Food Tech Grand Prix
Marintec Grand Prix
Lifetech Grand Prix

ABOUT

Outline of the event

point (e.g. of a statement)

Scientific and technological "seeds" are being created in universities, research institutes, and corporate laboratories, but it takes a lot of effort before they sprout into practical applications. The "Tech Planter," organized by LIVERNESS and its partners, is an ecosystem designed to serve as a planter to discover these seeds and help them sprout into business. The Biotech Grand Prix is a program aimed at discovering and fostering technology seeds and entrepreneurs in the real tech field (biotechnology, healthcare, medicine, drug discovery, medical devices, research tools, etc.).

Related Grand Prix :. List of Biotech Grand Prix

subject (of taxation, etc.)

Those who have a vision to change the world or improve the world based on the technological seeds in the real tech field and have a will to establish or develop a new business.
Individuals and teams are both welcome to participate, even before incorporation.
No limitation on the number of years of establishment, even if you are already a corporation. Even if you are close to mass production or PMF establishment, if you are planning to collaborate with partner companies, etc., it is acceptable.

Application Theme

Healthcare, energy, and agriculture infrastructure

Application period

Wednesday, March 1, 2023 - Friday, July 7, 2023

Screening Criteria

A panel of judges composed of LIVERNESS and its partners will review the following items

01novelty (patentability)
02feasibility
03Overseas Expansion Capabilities
04Are you going to change the world?
05passion

commendation

Grand Prize: (300,000 yen cash prize + right to receive 5 million yen business investment) 1
Corporate Prize: (200,000 yen) Approximately 10 prizes will be awarded.

SCHEDULE

Schedule

3/1[WED]: Entry Start

this way (direction close to the speaker or towards the speaker)Please register as a member and fill out the web form to apply. We also hold information sessions at universities and on an individual basis to encourage determination to enter and to teach tips on how to prepare documents. Please feel free to contact us for more information.

6/17[SAT]: kickoff

RIVANES and its partners, as well as entered teams, will meet and mingle.
Business consultation and partnership development with each other will be available. Participation or lack of participation on the day of the event will not be considered.

7/10[MON]: 1st round: Application Screening

A panel of judges composed of LIVERNESS and its partners will review the documents.
You will be asked to submit information about your team, skills, passions, and vision for the future via web form and video.
All applicants will be notified of the screening results and provided with feedback on their applications.
In addition, individual interviews (also online) for presentation review will be conducted for those who wish to participate.

8monthfirst 10 days of month: Finalists determined

Interviews will be held for applicants who pass the document screening to brush up their presentations for the final round.
In addition, meetings can be set up with partner companies for the purpose of business consultation and developing partnerships.

9/23[SAT]: Biotech Grand Prix

The 12 finalist teams that pass the document screening will be screened for presentation.

10Month～: Matching Support Period

After the Demo Day, the contact point between the venture and LIBANES will continue to be open for discussions on commercialization.
We handle a wide range of start-up issues, from incorporation to prototype development, financing, R&D, and more.
In addition, collaborative matching between ventures and partner companies has become more active to support business development.

PARTNER

ASSET

asset

ASSET01Riverness Communicator
ASSET02Partners
ASSET03Professional Supporter
ASSET04superfactory group

SUPPORT

Support

SUPPORT01Organize the purpose and vision of starting a business
SUPPORT02Brush up on your presentation
SUPPORT03Providing opportunities for business company collaboration
SUPPORT04Support for R&D and prototype development
SUPPORT05Support for knowledge and IP strategies
SUPPORT06finance

DEMO DAY

Grand Prix Outline

Grand Prix Name

Biotech Grand Prix 2023

Location

Center of Garage (1-16-3 Yokogawa, Sumida-ku, Tokyo)

Date & Time

Saturday, September 23, 2023, 13:00-19:00

Application period

Wednesday, March 1, 2023 - Friday, July 7, 2023

Participation Target

Held on a closed, pre-registration basis (finalists, partner companies, professional supporters, Super Factory Group)

organizing

Leave a Nest Co., Ltd.

timeline

12:30-13:00: inauguration
13:00-13:30: Greetings from the Organizer
13:30-17:00: Presentation (Presenter①～⑫)
17:00-18:00: Review Time
18:00-19:00: Announcement of Judging Results and Award Ceremony

JUDGE

judge

head judge
Executive Officer, LIVERNESS Co.
Hiroyuki Takahashi

D. from Yokohama City University in 2009. D. in Science, focusing on creating new research projects between industry and young researchers, including the launch of the "Liberace Research Fund" for young researchers under the age of 40. In addition, he continues to organize the "Super Interdisciplinary Society," a place to generate new knowledge and seeds for research and development by combining individual knowledge, technology, and passion for problem solving without being bound by the framework of academia.
Senior Manager, Health Science Division, Kirin Holdings Company, Limited
Shigehito Ikushima

2004 Joined Kirin Brewery Company (now Kirin Holdings Company, Limited). D. in Agriculture. D. in Agricultural Science, working on solving social issues based on fermentation and biotechnology. In the age of 100 years of life, he is particularly interested in technologies related to immunity, the intestinal environment, and substance production in order to contribute to people's health.
Deputy Director, Frontier Research Center, Taisho Pharmaceutical Co.
Shinichi Nishimoto

Dr. Kato joined Taisho Pharmaceutical in 1997. In 2019, he moved to the newly established Frontier Research Center, where he started startup investments and collaborations aimed at creating new businesses in the healthcare and drug discovery fields. He will assume his current position in April 2022.
Deputy Head of Unit 1, Medical Healthcare Division, DNP
Junichi Kondo

Joined the company in 1986. After working in the materials R&D and human resource development divisions, he was engaged in total solution planning and development in the medical and pharmaceutical fields in the Information and Communication Business Division from 1997. He also worked on medical device program development, etc. After serving as General Manager of Marketing Solution Division, C&I Division in 2012, General Manager of Consulting Division, and General Manager of Kansai Planning and Development Division, Information Innovation Division, he has been in his current position since 2019. 2023 also serves as Executive Officer of CMIC CMO Corporation.
Manager, New Business Management Division, DIC Corporation
Daisuke Tagawa

After working for a major chemical manufacturer and a healthcare manufacturer, he is currently struggling to launch a new business within a major company at DIC Corporation. His background is in polymer science. After conducting structural control research on hydrophilic resins and urethane resins at a major chemical manufacturer, he developed a number of functional chemical products. He was the youngest person at the time to receive the Best Invention of the Year Award. At a healthcare manufacturer, he planned a wide range of new businesses for pharmaceutical, food, and industrial applications using the food capsule technology that was his base technology, and at DIC, he launched the "Laboratory of Five Senses and Kansei" project to create new value through sensory evaluation and design.
Manager, D-LAB, Japan Tobacco Inc.
Shintaro Yoneyama

2019 Completed Master's program in Fundamental Science and Engineering, Graduate School of Science and Engineering, Keio University. While conducting theoretical research on statistical causal inference and adjustment for missing data, she also worked as a research assistant, analyzing data on the mental and physical health of the elderly. In May 2023, she joined Japan Tobacco Inc.
General Manager, Future Technology Creation Center, R&D Headquarters, Mitsui Chemicals, Inc.
Yoshiichi Uehara

After joining Mitsui Chemicals, Inc. in 1992, he was engaged in process development and industrialization of chemicals, followed by the development of next-generation process platform technologies such as biomass utilization, energy conservation and low-carbon technologies. He has been in his current position since April 2022.
D. (Agriculture), Laboratory Director, Wellness Science Lab, Meiji Holdings Co.
Masashi Nagata

After joining Meiji Dairies Corporation (currently Meiji Co., Ltd.) in 1995, he was in charge of fundamental research and product development research related to infant formulas and other nutritions, a visiting researcher at the University of California, Davis, and the general manager of product development for domestic and overseas businesses. Wellness Science Lab). He has also served as a part-time lecturer at Iwate University and as an expert committee member of Codex, the international standard for food products, at the Food Industry Center and other organizations.
President and CEO, Metagen, Inc.
Masatsugu Fukuda

After completing his doctorate at the Graduate School of Agriculture, Meiji University in 2006, he worked as a special researcher at RIKEN's Institute for Basic Sciences before becoming a specially-appointed associate professor at the Institute for Advanced Biosciences at Keio University in 2012 and a specially-appointed professor there in 2019. In 2015, he won the Grand Prize at the 1st Bioscience Grand Prix (now Biotech Grand Prix) for his business plan "Healthy Society Created from Stool" and established Metagen, Inc. He was appointed President and CEO. He specializes in intestinal design studies.
General Manager, Topical and Hair Care Product Development Department, Rohto Pharmaceutical Co.
Toru Nagamama

He graduated from the Graduate School of Pharmaceutical Sciences, Tokyo University of Science in 1992. In January 2023, he joined Rohto Pharmaceutical Co., Ltd. and has been engaged in research and development of topical OTC drugs and hair care products. He is a councilor of the Japanese Society of Cosmetic Science and Technology, and a board member of the Japanese Society of Cosmetic Medicine. He is also a board member of the Japanese Society of Cosmetic Medicine. Doctor of Engineering. Pharmacist.

FINALIST

finalist

Farmeranta Corporation

Representative] Akira Nakagawa

Microbial fermentation production of rare plant-derived ingredients by synthetic biology
Using a unique artificial strain construction technology based on synthetic biology, we combine genes from various species to construct efficient modified biosynthetic pathways for arbitrary compounds. This enables low-cost, scalable fermentation and production of compounds that are difficult to extract or synthesize.
Grand Prize/Metagen Award

MOLMIL Corporation

Representative] Eiichiro Mori

Capturing Molecular Movements to Develop Therapeutic Agents
By combining CHEmir (AI-assisted analytic chemistry), which looks at a wide range of molecular states, and MAGmir (NMR-based molecular dynamics), which looks at the atomic level.
PITTAN Corporation

Representative] Hirotaka Koyama

Sweat Analysis for Inner Care
Inner care, which focuses on nutritional components to change behavior, is important for achieving unwellness and healthy beauty. Therefore, we are developing a service that can easily track amino acid balance, which is central to inner care, using our original ultra-trace sweat analysis technology.
Mitsui Chemicals Award

Molecular Robotics Research Institute, Inc.

Representative] Akihiko Kohase

Democratization of Molecular Robots
Molecular robots made from biomolecules such as DNA and proteins have various possibilities in pharmaceuticals, agro-industry, energy applications, etc. Aiming to create a market by integrating AI/VR technology, nano-production processing technology, DNA manipulation technology, recycling agro-industry, and pharmaceutical development.
Kirin Group Award

Platinum Bio Inc.

Representative] Atsuhiro Ishii

Platform for designing biofunctions
CO₂The project aims to contribute to the realization of a carbon-recycling society by using bioinformatics (bio-DX) technology to optimize the best strains and breeding conditions of microalgae that produce useful substances from carbon dioxide (CO2), and by using genome editing technology to enhance the functionality of these strains.
Real Tech Fund Award

Circular Incubator

Representative] Tatsuki Kagitani

Flow to Food for the Future
The inside of the annularly joined tubes are filled with culture medium and cells/microorganisms. The tubes are shaken like a pendulum to generate an oscillation-induced circulating flow within the tubes for floating culture. By utilizing natural energy such as tidal currents, we aim to establish an environmentally friendly and low-cost culture technology.
Roth Prize

HiBisCus-Lab

Representative】Yuki Furuyama

Construction of a novel model culture system for indigenous skin flora
Construction of a novel model culture system for skin microflora We will develop a technique to extract the entire skin microflora and culture it in vitro. Using the developed culture system, we will elucidate the principle of disbiosis in atopic dermatitis and psoriasis, and the effects of the disbiosis on the diseases.
DNP Award

NGENIESS Biosciences

Representative] Akira Onoda

Technology to utilize proteins and enzymes by aligning their orientation
The technology to immobilize proteins and enzymes in aligned orientation by N-terminal modification will be applied to biopharmaceuticals and diagnostics. Aiming for innovation in biomaterials by utilizing 100% for protein and enzyme functions.
visualizeGene

Representative] Takayuki Shibata

All-in-One Genetic Testing System
By applying microfluidic chip technology to provide technology that enables multiple types of genetic testing to be performed quickly, easily, at low cost, and on-site (onsite) in a single work process, we will protect people's lives and health from infectious diseases and support safe and secure living.
Dog & Cat Cell Tech Lab

Representative] Motoko Morimoto

Development of Infinitely Dividing Cells for Drug Discovery in Dogs and Cats
We aim to develop new animal welfare-friendly formulations by developing canine and feline infinitely dividing cells, which have been difficult to culture until now, and by constructing a new drug efficacy evaluation system using genetic analysis.
DIC Award

Sensitivity Metric Bank

Representative] Kazuo Shibuta

Service of the "Sensitivity Metric Bank"
We want to create products that appeal to people's senses, but how do we measure sensibility? The "Kansei Metric Bank" service provides a "measure" to correctly measure the value of sensitivity, which was developed through joint research with many companies.
Meiji Holdings Award

Sugar Solutions

Representative] Toshiharu Nagatsuka

Development of database-assisted glycan sequencer
Glycan molecules are expected to be used not only for basic life sciences but also for industrial applications such as clinical biomarkers, but the difficulty of molecular structure analysis has hindered their development. To meet this need, we are aiming to develop a glycan sequencer for rapid and automated analysis.